Also trades as: CEVI.ST (STO) · $vol 1M

$14.00

+0.00 (+0.00%)

OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 48 · $333.9M mcap · 14M float · 0.0002% daily turnover · Short 100% of daily vol

Revenue

$759M +4.9% ▲

5Y CAGR: +10.0%

Gross Profit

$520M +6.7% ▲

5Y CAGR: +10.7%

Operating Income

$202M +13.7% ▲

5Y CAGR: +12.9%

Net Income

$153M +8.8% ▲

5Y CAGR: +11.3%

EPS (Diluted)

$6.42 +8.8% ▲

5Y CAGR: +11.4%

EBITDA

$237M +7.7% ▲

5Y CAGR: +12.0%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$566M	$639M	$677M	$723M	$759M
YoY Growth	+20.0%	+13.0%	+5.9%	+6.8%	+4.9%
Cost of Revenue	$173M	$201M	$214M	$236M	$239M
Gross Profit	$392M	$438M	$463M	$487M	$520M
Gross Margin	69.4%	68.6%	68.4%	67.3%	68.5%
R&D Expenses	$64M	$89M	$83M	$87M	$98M
SG&A Expenses	$165M	$191M	$213M	$222M	$220M
Operating Expenses	$230M	$280M	$296M	$309M	$318M
Operating Income	$163M	$158M	$167M	$178M	$202M
Operating Margin	28.8%	24.8%	24.7%	24.6%	26.6%
Interest Expense	$2M	$2M	$3M	$2M	$11M
Income Before Tax	$158M	$148M	$164M	$177M	$194M
Tax Expense	$33M	$30M	$34M	$36M	$41M
Net Income	$125M	$118M	$130M	$141M	$153M
Net Margin	22.2%	18.5%	19.2%	19.5%	20.2%
EPS (Diluted)	$5.25	$4.96	$5.46	$5.90	$6.42
EBITDA	$194M	$191M	$207M	$220M	$237M
Shares Outstanding	24M	24M	24M	24M	24M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$179M	$187M	$195M	$191M	$176M	$197M	$166M	$198M
Cost of Revenue	$57M	$58M	$58M	$62M	$54M	$65M	$52M	$59M
Gross Profit	$121M	$129M	$137M	$130M	$121M	$132M	$114M	$140M
Gross Margin	67.9%	69.2%	70.4%	67.7%	69.1%	66.8%	68.5%	70.4%
R&D Expenses	$26M	$20M	$25M	$22M	$29M	$22M	$30M	$30M
SG&A Expenses	$57M	$58M	$56M	$57M	$53M	$55M	$56M	$70M
Operating Expenses	$83M	$78M	$80M	$79M	$82M	$77M	$85M	$99M
Operating Income	$38M	$51M	$57M	$50M	$40M	$55M	$28M	$41M
Operating Margin	21.5%	27.5%	29.3%	26.3%	22.5%	27.9%	17.1%	20.6%
Interest Expense	$582K	$3M	$5M	$4M	$395K	$951K	$459K	$591K
Income Before Tax	$39M	$51M	$53M	$48M	$39M	$55M	$28M	$41M
Tax Expense	$8M	$11M	$11M	$10M	$8M	$12M	$6M	$8M
Net Income	$31M	$41M	$42M	$38M	$31M	$43M	$23M	$32M
Net Margin	17.4%	21.9%	21.3%	19.7%	17.8%	21.6%	13.5%	16.3%
EPS (Diluted)	$1.30	$1.72	$1.74	$1.58	$1.31	$1.79	$0.94	$1.35
EBITDA	$47M	$64M	$58M	$52M	$40M	$55M	$37M	$54M
Shares Outstanding	24M	24M	24M	24M	24M	24M	24M	24M

CLVSF OTC